United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025
Date: Jun-2019 | Id: MACRC-0103 | Geographical Scope: United States | Publisher: DPI Research
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025.
“United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues, and provides forecasts through 2025. The report provides a clear insight into current and future developments of the United States pneumococcal & meningococcal vaccine market. The report also explores detailed analysis of the top 6 vaccine market assessment in the United States from 2015 to 2018 and forecasts to 2025.
The report also details the latest information about the pneumococcal & meningococcal vaccine pricing trends and analysis. It also covers reimbursement patterns and offers a clear view of the regulatory landscape. Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement, and partnerships are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccine market.
The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio, and recent development.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline (GSK)
Top 6 Vaccines Covered Under This Report Are:
• Prevnar / Prevnar 13
• Pneumovax 23
• Menactra
• Bexsero
• Menveo
• Trumenba
The Latest Industry Data Included in this Report:
• United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
• United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
• United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
• United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies
• United States Pneumococcal & Meningococcal Vaccines Regulatory System
• Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
• Major Deals in the Vaccines Market
• Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
• Major Companies Analysis
The Report Answers the Following Questions about the United States Pneumococcal & Meningococcal Vaccines Market:
• What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 – 2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which vaccine provides the highest market share?
• How are the overall market and vaccines type growing?
• What are the key drivers and inhibitors in the current market?
• What are the various pneumococcal & meningococcal vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?
“United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues, and provides forecasts through 2025. The report provides a clear insight into current and future developments of the United States pneumococcal & meningococcal vaccine market. The report also explores detailed analysis of the top 6 vaccine market assessment in the United States from 2015 to 2018 and forecasts to 2025.
The report also details the latest information about the pneumococcal & meningococcal vaccine pricing trends and analysis. It also covers reimbursement patterns and offers a clear view of the regulatory landscape. Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement, and partnerships are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccine market.
The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio, and recent development.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline (GSK)
Top 6 Vaccines Covered Under This Report Are:
• Prevnar / Prevnar 13
• Pneumovax 23
• Menactra
• Bexsero
• Menveo
• Trumenba
The Latest Industry Data Included in this Report:
• United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
• United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
• United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
• United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies
• United States Pneumococcal & Meningococcal Vaccines Regulatory System
• Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
• Major Deals in the Vaccines Market
• Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
• Major Companies Analysis
The Report Answers the Following Questions about the United States Pneumococcal & Meningococcal Vaccines Market:
• What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 – 2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which vaccine provides the highest market share?
• How are the overall market and vaccines type growing?
• What are the key drivers and inhibitors in the current market?
• What are the various pneumococcal & meningococcal vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?
1. Executive Summary 2. United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025) 3. United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025) 4. United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025) 5. United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025 5.1 United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025 5.2 United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025 6. Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market 6.1 Market Drivers 6.2 Market Inhibitors 7. United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025 7.1 Prevnar / Prevnar 13 7.2 Pneumovax 23 7.3 Menactra 7.4 Bexsero 7.5 Menveo 7.6 Trumenba 8. United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis 9. United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies & Regulatory System 9.1 Reimbursement Policies 9.2 Regulation System 10. Promising Pneumococcal & Meningococcal Vaccines in Clinical Development 11. Major Deals in the Vaccines Market 11.1 Merger & Acquisitions 11.2 Collaboration Deals 11.3 Licensing Agreement 11.4 Exclusive Agreement 11.5 Distribution Agreement 11.6 Partnerships 12. Key Companies Analysis 12.1 Sanofi Pasteur 12.1.1 Business Overview 12.1.2 Vaccines Portfolio 12.1.3 Recent Development 12.2 GlaxoSmithKline (GSK) 12.2.1 Business Overview 12.2.2 Vaccines Portfolio 12.2.3 Recent Development 12.3 Merck 12.3.1 Business Overview 12.3.2 Vaccines Portfolio 12.3.3 Recent Development 12.4 Pfizer 12.4.1 Business Overview 12.4.2 Vaccines Portfolio 12.4.3 Recent Development
Related reports
United States Influenza Vaccine Market
$1000-$1400
United States Blood Glucose Test Strips Market
$1290-$1990